Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2023 Earnings Call Transcript

Page 2 of 2

Christopher Missling: Yeah. So again, thank you very much. And we’re looking forward, and we’re very excited about the company’s potential as well as to build on the biomarker-driven precision medicine studies with significant unmet medical need and addressing undertreated economic burden. And we’re looking forward to the upcoming data readout in the Alzheimer’s disease study and the pediatric Rett syndrome study. Thank you very much. Looking forward.

Clint Tomlinson: Thank you, ladies and gentlemen. This concludes today’s conference, and we appreciate you participating. You may now disconnect.

Follow Anavex Life Sciences Corp. (NASDAQ:AVXL)

Page 2 of 2